Increased immunohistochemical expression of thrombomodulin at placental perivascular myofibroblast in severe preeclampsia (PE)

Histology and Histopathology

Volumn 20, Issue 4, 2005, Pages 1045-1055

  Bosco, Cleofina ^a   Parra, M ^b   Barja, P ^a   Rodrigo, R ^a   Fernandez V ^a   Suarez, M ^a   Munoz H ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Immunohistochemical thrombomodulin; Placental endothelium; Preeclampsia

Indexed keywords

MONOCLONAL ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; THROMBOMODULIN;

ARTERY ENDOTHELIUM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOFIBROBLAST; PLACENTA CIRCULATION; PLACENTA VILLUS; PREECLAMPSIA; PREGNANT WOMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SYNCYTIOTROPHOBLAST;

ACTINS; ADULT; BIOLOGICAL MARKERS; FEMALE; FIBRIN; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; MUSCLE, SMOOTH, VASCULAR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY PROTEINS; SEVERITY OF ILLNESS INDEX; THROMBOMODULIN;

EID: 27144512268     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Benyo D.F., Smarason A., Redman C.W., Sims C. and Conrad K.P. (2001). Expression of inflammatory cytokines in placentas from women with preeclampsia. J. Clin. Endocrinol. Metab. 86, 2505-2512.
2. Bosco C. (1994). Morphology of the capillaries in the alpha and beta zone of human term placenta: the relationship between capillary morphology and the trophoblastic layer. Med. Sci. Res. 22, 115-117.
3. Bosco C. (2005). Alcohol and xenobiotics in placenta damage. In: Comprehensive handbook of alcohol related pathology. Vol 2. Preedy V.R. and Watson R.R. (eds). Elsevier Ltd. London. pp 921-935.
4. Bosco C., Manriquez F., Molina R. and Araya J. (1989). Placentas normales de término. Vellosidades coriónicas. Matriz extracelular figurada. Tipo de colágeno y su disposición en la vecindad de los capilares fetales detectados con la técnica de picro-Sirius. Rev. Med. Chile. 117, 1102-1107.
5. Burton G.J. and Jauniaux E. (2004). Placental oxidative stress: from miscarriage to preeclampsia. J. Soc. Gynecol. Invest. 11, 342-352.
6. Cone J.B., Ferrer T.J., Wallace B.H., Wang J. and Hauer-Jensen M. (2003). Alterations in endothelial thrombomodulin expression in zymosan-induced lung injury. J. Trauma 54, 731-736.
7. Conrad K.P., Miles T.M. and Benyo D.F. (1998). Circulating levels of immunoreactive cytokines in women with preeclampsia. Am. J. Reprod. Immunol. 40, 102-111.
8. Conway E.M. and Rosenberg R.D. (1988). Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol. Cell Biol. 8, 5588-5592.
9. Chun D., Braga C., Chow C. and Lok L. (1964). Clinical observation on some aspects of hydatidiform moles. J. Obstet. Gynaecol. Br. Comnwlth. 74, 180-184.
10. Demir R., Kosanke G., Kohnen G., Kertschanska S. and Kaufmann P. (1997). Classification of human placental stem villi: review of structural and functional aspects. Microsc. Res. Tech. 38, 29-41.
11. Di Federico E., Genbacev O. and Fisher S.J. (1999). Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am. J. Pathol. 155, 293-301.
12. Dittman W.A. and Majerus P.W. (1990). Structure and function of thrombomodulin: a natural anticoagulant. Blood 75, 329-336.
13. Esmon C.T. (2000). Regulation of blood coagulation. Biochim. Biophys. Acta 1477, 349-360.
14. Estelles A., Gilabert J., Espana F., Aznar J. and Galbis M. (1991). Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Am. J. Obstet. Gynecol. 165, 138-142.
15. Estelles A., Gilabert J., Grancha S., Yamamoto K., Thinnes T., Espana F., Aznar J. and Loskutoff D.J. (1998). Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb. Haemost. 79, 500-508.
16. Fazel A., Vincenot A., Malassine A., Soncin F., Gaussem P., Alsat E. and Evain Brion D. (1998). Increase in expression and activity of thrombomodulin in term human syncytiotrophoblast microvilli. Placenta 19, 261-268.
17. Feller A.C., Schneider H., Schmidt D. and Parwaresch M.R. (1985). Myofibroblast as a major cellular constituent of villous stroma in human placenta. Placenta 6, 405-415.
18. Fernandez G.C., Te Loo M.W., van der Velden T.J., van der Heuvel L.P., Palermo M.S. and Monnens L.L. (2003). Decrease of thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome. Pediatr. Nephrol. 18, 1066-1068.
19. Graf R., Langer J.U., Schonfelder G., Oney T., Hartel-Schenk S., Reutter W. and Schmidt H.H. (1994). The extravascular contractile system in the human placenta. Morphological and immunocytochemical investigations. Anat. Embryol. (Berl). 190, 541-548.
20. Graf R., Matejevic D., Schuppan D., Neudeck H., Shakibaci M. and Vetter K. (1997). Molecular anatomy of the perivascular sheath in human placental stem villi: the contractile apparatus and its association to the extracellular matrix. Cell Tissue Res. 290, 601-607.
21. Grinnell B.W. and Berg D.T. (1996). Surface thrombomodulin modulates thrombin receptor responses on vascular smooth muscle cells. Am. J. Physiol. 270, H 603-609.
22. Heldin C H. (1992). Structural and functional studies on platelet-derived growth factor. EMBO J. 11, 4251-4259.
23. Helske S., Vuorela P., Carpen O., Hornig C., Weich H. and Halmesmaki E. (2001). Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol. Hum. Reprod. 7, 205-210.
24. Ikeda T., Ishii H., Higuchi T., Sato K., Hayashi Y., Ikeda K. and Hirabayashi Y. (2000). Localization of Thrombomodulin in the anterior segment of the human eye. Invest. Ophtalmol. Vis. Sci. 41, 3383-3390.
25. Ishii H., Uchiyama H. and Kazama M. (1991). Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb. Haemost. 65. 618-623.
26. Ishii H., Tazuka T., Ishikawa H., Takada K., Oida K. and Horie S. (2003). Oxidized phospholipids in oxidized low-density lipoprotein down-regulate thrombomodulin transcription in vascular endothelial cells through a decrease in the binding of RARβ- RXRα heterodimers and Sp1 and Sp3 to their binding sequences in the TM promoter. Blood 101, 4765-4774.
27. Jin Z.G., Ueba H., Tanimoto T., Lungu A.O, Frame M.D. and Berk B.C. (2003). Ligand independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation on endothelial nitric oxide synthase. Circ. Res. 93, 354-363.
28. Kacemi A., Vervelle C., Uzan S. and Challier J.C. (1999). Immunostaining of vascular perivascular cells and stromal components in human placental villi. Cell. Mol. Biol. 45, 101-113.
29. Khalil R.A. and Granger J.P. (2002). Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R29-45.
30. Kanfer A., Bruch J.F., Nguyen G., He C.J., Delarue F., Flahault A., Nessmann C. and Uzan S. (1996). Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia. Lab. Invest. 74, 253-258.
31. Kapanci Y., Ribaux C., Chaponnier C. and Gabbiani G. (1992). Cytoskeletal features of alveolar myofibroblast and pericytes normal human and rat lung. J. Histochem. Cytochem. 40, 1955-1963.
32. Labarrere C. A. and Faulk W.P. (1992a). Microvascular perturbations in human allografts: analogies in preeclamptic placentae. Am. J. Reprod. Immunol. 27, 109-116.
33. Labarrere CA. and Faulk W.P. (1992b). Fetal stem vessel endothelial changes in placentae from normal and abnormal pregnancies. Am. J. Reprod. Immunol. 27, 97-100.
34. Lanir N., Aharon A. and Brenner B. (2003). Haemostatic mechanisms in human placenta. Best. Pract. Res. Clin. Haematol. 16, 183-195.
35. Lentz S.R., Tsiang M. and Sadler J.E. (1991). Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and post-transcriptional mechanisms. Blood 77, 542-550.
36. Li Y., Zheng J., Bird I.M. and Magness R.R. (2003). Effects of pulsatile shear stress on nitric oxide production and endothelial cell nitric oxide synthase expression by ovine fetoplacental artery endothelial cells. Biol. Reprod. 69, 1053-1059.
37. Lyall F., Young., A, Boswell F., Kingdom J.C. and Greer I.A. (1997). Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by preeclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 18, 269-276.
38. Madazli R., Benian A., Aydin S., Uzun H. and Tolun N. (2002). The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in pre-eclampsia. J. Obstet. Gynaecol. 22, 477-480.
39. Malek A.M., Jackman R., Rosenberg R.D. and Izumo S. (1994). Endothelial expression of thrombomodulin is reversible regulated by fluid shear stress. Circ. Res. 74, 852-860.
40. Many A., Hubel C.A., Fisher S.J., Roberts J.M. and Zhou Y. (2000). Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am. J. Pathol. 156, 321-331.
41. Maruyama I. and Majerus P.W. (1985). The turnover of thrombin-thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin. J. Biol. Chem. 15, 15432-15438.
42. Moore K.L., Esmon C.T. and Esmon N.L. (1989). Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 73, 159-185.
43. Myatt L. (1992). Control of vascular resistance in the human placenta. Placenta 13, 329-341.
44. Nakashima A., Kobayashi T. and Terao T. (1996). Fibrinolysis during normal pregnancy and severe preeclampsia: relationships between plasma levels of plasminogen activators and inhibitors. Gynecol. Obstet. Invest. 42, 95-101.
45. Nomura M., Yamagishi S., Harada S., Hayashi Y., Yamashima T., Yamashita J. and Yamamoto H. (1995). Posible participation of autocrine and paracrine vascular endotelial growth factors in hypoxia-induced proliferation of endotelial cells and pericytes. J. Biol. Chem. 270, 28316-28324.
46. Parra M., Rodrigo R., Barja P., Bosco C., Fernández V., Sepúlveda E., Aleuanlli C. and Matamala P. (2003). Oxidative stress and endothelial dysfunction is correlated with preeclampsia and fetal growth restriction. Ultasound. Obstet. Gynecol. 22, 75.
47. Redman C.W.C. (1991). Current topic: pre-eclampsia and the placenta. Placenta 12, 301-308.
48. Roes E.M., Sweep C.G., Thomas C.M., Zusterzeel P.L., Geurts-Moespot A., Peters W.H. and Steegers E.A. (2002). Levels of plasminogen activators and their inhibitors in maternal and umbilical cord plasma in severe preeclampsia. Am. J. Obstet. Gynecol. 187, 1019-1025.
49. Scott J.S. (1958). Pregnancy toxaemia associated with hydrops foetalis, hydatidiform mole and hydramnios. J. Obstet. Gynaecol. Br. Empire. 65, 689-701.
50. Sebire N.J. and Talbert D.G. (2001). The dynamic placenta: a closer look at the pathophysiology of placental hemodynamics in uteroplacental compromise. Ultrasound. Obstet. Gynecol. 18, 357-361.
51. Singh H. J., Rahman A., Larmie E. T. and Nila A. (2001) Endothelin-1 in feto placental tissues from normotensive pregnant women and women with pre-eclampsia. Acta Obstet. Gynecol. Scand. 80, 99-103.
52. Soff G.A., Jackman R.W. and Rosenberg F.D. (1991). Expression of thrombomodulin by smooth muscle cells in culture: Different effects of tumor necrosis factor and cyclic adenosine monophosphate on thrombomodulin expression by endothelial cells and smooth muscle cells in culture. Blood 77, 515-518.
53. Takagi H., King G.L. and Aiello L.P. (1996). Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes 45, 1016-1023.
54. Walsh S.W. and Wang Y. (1995). Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J. Clin. Endocrinol. Metab. 80, 1888-1893.
55. Yamagishi S., Yonekura H., Yamamoto Y., Fujimori H., Sakurai S., Tanaka N. and Yamamoto H. (1999). Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. Lab. Invest. 79, 501-509.
56. Yang H.L, Hseu Y.C, Lu F.J. and Tsai H.D. (1998). Humic acid reduces protein-C activating cofactor activity of thrombomodulin of human umbilical vein endothelial cells. Br. J. Haematol. 101, 16-23.
57. Zhou Y., Damsky C.H., Chiu K., Roberts J.M. and Fisher S.J. (1993). Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblast. J. Clin. Invest. 91, 950-960.